The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-UpYongfeng Si, Ying Qin, Guiping Lan et al.|Chemical and Pharmaceutical Bulletin|2016Cited by 49